Developmental regulation of antioxidant enzymes and their impact on neonatal lung disease

Antioxidants and Redox Signaling

Volumn 21, Issue 13, 2014, Pages 1837-1848

  Berkelhamer, Sara K ^a   Farrow, Kathryn N ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE;

CELL FUNCTION; CELL ORGANELLE; DEVELOPMENTAL STAGE; ENZYME ACTIVITY; ENZYME REGULATION; HOMEOSTASIS; HUMAN; LUNG DEVELOPMENT; LUNG DISEASE; LUNG INJURY; NEWBORN DISEASE; NONHUMAN; OXIDATIVE STRESS; PREMATURE LABOR; REVIEW; ANIMAL; LUNG; METABOLISM; NEWBORN; OXIDATION REDUCTION REACTION; PHYSIOLOGY;

ANIMALS; ANIMALS, NEWBORN; ANTIOXIDANTS; HUMANS; INFANT, NEWBORN; LUNG; LUNG DISEASES; OXIDATION-REDUCTION; OXIDATIVE STRESS;

EID: 84907916412     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5515     Document Type: Review

References (124)

1. Ahmed MN, Suliman HB, Folz RJ, Nozik-Grayck E, Golson ML, Mason SN, and Auten RL. Extracellular superoxide dismutase protects lung development in hyperoxia- exposed newborn mice. Am J Respir Crit Care Med 167: 400-405, 2003.
2. Ahola T, Lapatto R, Raivio KO, Selander B, Stigson L, Jonsson B, Jonsbo F, Esberg G, Stovring S, Kjartansson S, Stiris T, Lossius K, Virkola K, and Fellman V. N-acetylcysteine does not prevent bronchopulmonary dysplasia in immature infants: a randomized controlled trial. J Pediatr 143: 713-719, 2003.
3. Asikainen TM, Heikkila P, Kaarteenaho-Wiik R, Kinnula VL, and Raivio KO. Cell-specific expression of manganese superoxide dismutase protein in the lungs of patients with respiratory distress syndrome, chronic lung disease, or persistent pulmonary hypertension. Pediatr Pulmonol 32: 193-200, 2001.
4. Asikainen TM, Raivio KO, Saksela M, and Kinnula VL. Expression and developmental profile of antioxidant enzymes in human lung and liver. Am J Respir Cell Mol Biol 19: 942-949, 1998.
5. Asikainen TM and White CW. Pulmonary antioxidant defenses in the preterm newborn with respiratory distress and bronchopulmonary dysplasia in evolution: implications for antioxidant therapy. Antioxid Redox Signal 6: 155-167, 2004.
6. Asikainen TM and White CW. Antioxidant defenses in the preterm lung: role for hypoxia-inducible factors in BPD? Toxicol Appl Pharmacol 203: 177-188, 2005.
7. Aslam M, Baveja R, Liang OD, Fernandez-Gonzalez A, Lee C, Mitsialis SA, and Kourembanas S. Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease. Am J Respir Crit Care Med 180: 1122-1130, 2009.
8. Auten RL, Jr., Mason SN, Tanaka DT, Welty-Wolf K, and Whorton MH. Anti-neutrophil chemokine preserves alveolar development in hyperoxia-exposed newborn rats. Am J Physiol Lung Cell Mol Physiol 281: L336-L344, 2001.
9. Auten RL, Mason SN, Whorton MH, Lampe WR, Foster WM, Goldberg RN, Li B, Stamler JS, and Auten KM. Inhaled ethyl nitrite prevents hyperoxia-impaired postnatal alveolar development in newborn rats. Am J Respir Crit Care Med 176: 291-299, 2007.
10. Auten RL, O'Reilly MA, Oury TD, Nozik-Grayck E, and Whorton MH. Transgenic extracellular superoxide dismutase protects postnatal alveolar epithelial proliferation and development during hyperoxia. Am J Physiol Lung Cell Mol Physiol 290: L32-L40, 2006.
11. Auten RL, Whorton MH, and Nicholas Mason S. Blocking neutrophil influx reduces DNA damage in hyperoxiaexposed newborn rat lung. Am J Respir Cell Mol Biol 26: 391-397, 2002.
12. Autor AP, Frank L, and Roberts RJ. Developmental characteristics of pulmonary superoxide dismutase: relationship to idiopathic respiratory distress syndrome. Pediatr Res 10: 154-158, 1976.
13. Babu TA and Sharmila V. Vitamin A supplementation in late pregnancy can decrease the incidence of bronchopulmonary dysplasia in newborns. J Matern Fetal Neonatal Med 23: 1468-1469, 2010.
14. Ballard PL, Truog WE, Merrill JD, Gow A, Posencheg M, Golombek SG, Parton LA, Luan X, Cnaan A, and Ballard RA. Plasma biomarkers of oxidative stress: relationship to lung disease and inhaled nitric oxide therapy in premature infants. Pediatrics 121: 555-561, 2008.
15. Barreto M, Villa MP, Olita C, Martella S, Ciabattoni G, and Montuschi P. 8-Isoprostane in exhaled breath condensate and exercise-induced bronchoconstriction in asthmatic children and adolescents. Chest 135: 66-73, 2009.
16. Berkelhamer SK, Kim GA, Radder JE, Wedgwood S, Czech L, Steinhorn RH, and Schumacker PT. Developmental differences in hyperoxia-induced oxidative stress and cellular responses in the murine lung. Free Radic Biol Med 61C: 51-60, 2013.
17. Beyer W, Imlay J, and Fridovich I. Superoxide dismutases. Prog Nucleic Acid Res Mol Biol 40: 221-253, 1991.
18. Bofan M, Mores N, Baron M, Dabrowska M, Valente S, Schmid M, Trove A, Conforto S, Zini G, Cattani P, Fuso L, Mautone A, Mondino C, Pagliari G, D'Alessio T, and Montuschi P. Within-day and between-day repeatability of measurements with an electronic nose in patients with COPD. J Breath Res 7: 017103, 2013.
19. Bohr VA, Stevnsner T, and de Souza-Pinto NC. Mitochondrial DNA repair of oxidative damage in mammalian cells. Gene 286: 127-134, 2002.
20. Bonikos DS, Bensch KG, Ludwin SK, and Northway WH, Jr. Oxygen toxicity in the newborn. The effect of prolonged 100 per cent O2 exposure on the lungs of newborn mice. Lab Invest 32: 619-635, 1975.
21. Bridges JP, Davis HW, Damodarasamy M, Kuroki Y, Howles G, Hui DY, and McCormack FX. Pulmonary surfactant proteins A and D are potent endogenous inhibitors of lipid peroxidation and oxidative cellular injury. J Biol Chem 275: 38848-38855, 2000.
22. Brion LP, Bell EF, and Raghuveer TS. Vitamin E supplementation for prevention of morbidity and mortality in preterm infants. Cochrane Database Syst Rev CD003665, 2003.
23. Budinger GR, Mutlu GM, Urich D, Soberanes S, Buccellato LJ, Hawkins K, Chiarella SE, Radigan KA, Eisenbart J, Agrawal H, Berkelhamer S, Hekimi S, Zhang J, Perlman H, Schumacker PT, Jain M, and Chandel NS. Epithelial cell death is an important contributor to oxidant- mediated acute lung injury. Am J Respir Crit Care Med 183: 1043-1054, 2011.
24. Chang LY, Subramaniam M, Yoder BA, Day BJ, Ellison MC, Sunday ME, and Crapo JD. A catalytic antioxidant attenuates alveolar structural remodeling in bronchopulmonary dysplasia. Am J Respir Crit Care Med 167: 57-64, 2003.
25. Cheah FC, Jobe AH, Moss TJ, Newnham JP, and Kallapur SG. Oxidative stress in fetal lambs exposed to intra-amniotic endotoxin in a chorioamnionitis model. Pediatr Res 63: 274-279, 2008.
26. Cheng Y, Cai H, Yin B, and Yao P. Cholic acid modified N-(2-hydroxy)-propyl-3-trimethylammonium chitosan chloride for superoxide dismutase delivery. Int J Pharm 454: 425-434, 2013.
27. Chessex P, Watson C, Kaczala GW, Rouleau T, Lavoie ME, Friel J, and Lavoie JC. Determinants of oxidant stress in extremely low birth weight premature infants. Free Radic Biol Med 49: 1380-1386, 2010.
28. Chouteau JM, Obiako B, Gorodnya OM, Pastukh VM, Ruchko MV, Wright AJ, Wilson GL, and Gillespie MN. Mitochondrial DNA integrity may be a determinant of endothelial barrier properties in oxidant-challenged rat lungs. Am J Physiol Lung Cell Mol Physiol 301: L892- L898, 2011.
29. Clerch LB and Massaro D. Tolerance of rats to hyperoxia. Lung antioxidant enzyme gene expression. J Clin Invest 91: 499-508, 1993.
30. Cole FS, Alleyne C, Barks JD, Boyle RJ, Carroll JL, Dokken D, Edwards WH, Georgieff M, Gregory K, Johnston MV, Kramer M, Mitchell C, Neu J, Pursley DM, Robinson WM, and Rowitch DH. NIH Consensus Development Conference statement: inhaled nitric-oxide therapy for premature infants. Pediatrics 127: 363-369, 2011.
31. Comporti M, Signorini C, Leoncini S, Buonocore G, Rossi V, and Ciccoli L. Plasma F2-isoprostanes are elevated in newborns and inversely correlated to gestational age. Free Radic Biol Med 37: 724-732, 2004.
32. Cotton RB, Hazinski TA, Morrow JD, Roberts LJ, Zeldin DC, Lindstrom DP, Lappalainen U, Law AB, and Steele S. Cimetidine does not prevent lung injury in newborn premature infants. Pediatr Res 59: 795-800, 2006.
33. Crapo JD. Morphologic changes in pulmonary oxygen toxicity. Annu Rev Physiol 48: 721-731, 1986.
34. Darlow BA and Graham PJ. Vitamin A supplementation to prevent mortality and short- and long-term morbidity in very low birthweight infants. Cochrane Database Syst Rev CD000501, 2011.
35. Darlow BA, Winterbourn CC, Inder TE, Graham PJ, Harding JE, Weston PJ, Austin NC, Elder DE, Mogridge N, Buss IH, and Sluis KB. The effect of selenium supplementation on outcome in very low birth weight infants: a randomized controlled trial. The New Zealand Neonatal Study Group. J Pediatr 136: 473-480, 2000.
36. Das KC, Guo XL, and White CW. Induction of thioredoxin and thioredoxin reductase gene expression in lungs of newborn primates by oxygen. Am J Physiol 276: L530- L539, 1999.
37. Das KC, Pahl PM, Guo XL, and White CW. Induction of peroxiredoxin gene expression by oxygen in lungs of newborn primates. Am J Respir Cell Mol Biol 25: 226-232, 2001.
38. Davis J. Pharmacological approaches to the therapy of chronic lung disease in the newborn. Semin Neonatol 3: 113-118, 1998.
39. Davis JM and Auten RL. Maturation of the antioxidant system and the effects on preterm birth. Semin Fetal Neonatal Med 15: 191-195, 2010.
40. Davis JM, Parad RB, Michele T, Allred E, Price A, and Rosenfeld W. Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismutase. Pediatrics 111: 469-476, 2003.
41. Dizdar EA, Uras N, Oguz S, Erdeve O, Sari FN, Aydemir C, and Dilmen U. Total antioxidant capacity and total oxidant status after surfactant treatment in preterm infants with respiratory distress syndrome. Ann Clin Biochem 48: 462-467, 2011.
42. Dobashi K, Asayama K, Hayashibe H, Munim A, Kawaoi A, Morikawa M, and Nakazawa S. Immunohistochemical study of copper-zinc and manganese superoxide dismutases in the lungs of human fetuses and newborn infants: developmental profile and alterations in hyaline membrane disease and bronchopulmonary dysplasia. Virchows Arch A Pathol Anat Histopathol 423: 177-184, 1993.
43. Doyle LW and Anderson PJ. Long-term outcomes of bronchopulmonary dysplasia. Semin Fetal Neonatal Med 14: 391-395, 2009.
44. Fanaroff AA, Stoll BJ, Wright LL, Carlo WA, Ehrenkranz RA, Stark AR, Bauer CR, Donovan EF, Korones SB, Laptook AR, Lemons JA, Oh W, Papile LA, Shankaran S, Stevenson DK, Tyson JE, and Poole WK. Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol 196: 147.e1-e8, 2007.
45. Fardy CH and Silverman M. Antioxidants in neonatal lung disease. Arch Dis Child Fetal Neonatal Ed 73: F112- F117, 1995.
46. Farrell PM. Vitamin E deficiency in premature infants. J Pediatr 95: 869-872, 1979.
47. Farrow KN, Lakshminrusimha S, Reda WJ, Wedgwood S, Czech L, Gugino SF, Davis JM, Russell JA, and Steinhorn RH. Superoxide dismutase restores eNOS expression and function in resistance pulmonary arteries from neonatal lambs with persistent pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 295: L979- L987, 2008.
48. Farstad T, Bratlid D, Medbo S, and Markestad T. Bronchopulmonary dysplasia - prevalence, severity and predictive factors in a national cohort of extremely premature infants. Acta Paediatr 100: 53-58, 2011.
49. Fazzone H, Wangner A, and Clerch LB. Rat lung contains a developmentally regulated manganese superoxide dismutase mRNA-binding protein. J Clin Invest 92: 1278-1281, 1993.
50. Forman HJ and Thomas MJ. Oxidant production and bactericidal activity of phagocytes. Annu Rev Physiol 48: 669-680, 1986.
51. Frank L. Developmental aspects of experimental pulmonary oxygen toxicity. Free Radic Biol Med 11: 463-494, 1991.
52. Frank L, Bucher JR, and Roberts RJ. Oxygen toxicity in neonatal and adult animals of various species. J Appl Physiol 45: 699-704, 1978.
53. Frank L and Groseclose EE. Preparation for birth into an O2-rich environment: the antioxidant enzymes in the developing rabbit lung. Pediatr Res 18: 240-244, 1984.
54. Frank L, Lewis PL, and Sosenko IR. Dexamethasone stimulation of fetal rat lung antioxidant enzyme activity in parallel with surfactant stimulation. Pediatrics 75: 569-574, 1985.
55. Frank L and Sosenko IR. Prenatal development of lung antioxidant enzymes in four species. J Pediatr 110: 106-110, 1987.
56. Frank L and Sosenko IR. Failure of premature rabbits to increase antioxidant enzymes during hyperoxic exposure: increased susceptibility to pulmonary oxygen toxicity compared with term rabbits. Pediatr Res 29: 292-296, 1991.
57. Fridovich I and Freeman B. Antioxidant defenses in the lung. Annu Rev Physiol 48: 693-702, 1986.
58. Georgeson GD, Szony BJ, Streitman K, Varga IS, Kovacs A, Kovacs L, and Laszlo A. Antioxidant enzyme activities are decreased in preterm infants and in neonates born via caesarean section. Eur J Obstet Gynecol Reprod Biol 103: 136-139, 2002.
59. Gitto E, Pellegrino S, D'Arrigo S, Barberi I, and Reiter RJ. Oxidative stress in resuscitation and in ventilation of newborns. Eur Respir J 34: 1461-1469, 2009.
60. Giusti B, Vestrini A, Poggi C, Magi A, Pasquini E, Abbate R, and Dani C. Genetic polymorphisms of antioxidant enzymes as risk factors for oxidative stress-associated complications in preterm infants. Free Radic Res 46: 1130-1139, 2012.
61. Goldberg JA, Guzman JN, Estep CM, Ilijic E, Kondapalli J, Sanchez-Padilla J, and Surmeier DJ. Calcium entry induces mitochondrial oxidant stress in vagal neurons at risk in Parkinson's disease. Nat Neurosci 15: 1414-1421, 2012.
62. Hazinski TA and Cotton, R.B. Oxidant Toxicity and Oxidant Stress in the Developing Lung. Semin Neonatol 3: 103-111, 1998.
63. Ho YS. Transgenic and knockout models for studying the role of lung antioxidant enzymes in defense against hyperoxia. Am J Respir Crit Care Med 166: S51-S56, 2002.
64. Hodson WA, Truog WE, Mayock DE, Lyrene R, and Woodrum DE. Bronchopulmonary dysplasia: the need for epidemiologic studies. J Pediatr 95: 848-851, 1979.
65. Ischiropoulos H, Nadziejko CE, Kumae T, and Kikkawa Y. Oxygen tolerance in neonatal rats: role of subcellular superoxide generation. Am J Physiol 257: L411-L420, 1989.
66. Jain A, Mehta T, Auld PA, Rodrigues J, Ward RF, Schwartz MK, and Martensson J. Glutathione metabolism in newborns: evidence for glutathione deficiency in plasma, bronchoalveolar lavage fluid, and lymphocytes in prematures. Pediatr Pulmonol 20: 160-166, 1995.
67. Joung KE, Kim HS, Lee J, Shim GH, Choi CW, Kim EK, Kim BI, and Choi JH. Correlation of urinary inflammatory and oxidative stress markers in very low birth weight infants with subsequent development of bronchopulmonary dysplasia. Free Radic Res 45: 1024-1032, 2011.
68. Kaarteenaho-Wiik R and Kinnula VL. Distribution of antioxidant enzymes in developing human lung, respiratory distress syndrome, and bronchopulmonary dysplasia. J Histochem Cytochem 52: 1231-1240, 2004.
69. Kobaly K, Schluchter M, Minich N, Friedman H, Taylor HG, Wilson-Costello D, and Hack M. Outcomes of extremely low birth weight ( < 1 kg) and extremely low gestational age ( < 28 weeks) infants with bronchopulmonary dysplasia: effects of practice changes in 2000 to 2003. Pediatrics 121: 73-81, 2008.
70. Lander HM. An essential role for free radicals and derived species in signal transduction. FASEB J 11: 118-124, 1997.
71. Lowes DA, Wallace C, Murphy MP, Webster NR, and Galley HF. The mitochondria targeted antioxidant MitoQ protects against fluoroquinolone-induced oxidative stress and mitochondrial membrane damage in human Achilles tendon cells. Free Radic Res 43: 323-328, 2009.
72. Lucidi V, Ciabattoni G, Bella S, Barnes PJ, and Montuschi P. Exhaled 8-isoprostane and prostaglandin E(2) in patients with stable and unstable cystic fibrosis. Free Radic Biol Med 45: 913-919, 2008.
73. Martin WJ, 2nd, Gadek JE, Hunninghake GW, and Crystal RG. Oxidant injury of lung parenchymal cells. J Clin Invest 68: 1277-1288, 1981.
74. Mata-Greenwood E, Jenkins C, Farrow KN, Konduri GG, Russell JA, Lakshminrusimha S, Black SM, and Steinhorn RH. eNOS function is developmentally regulated: uncoupling of eNOS occurs postnatally. Am J Physiol Lung Cell Mol Physiol 290: L232-L241, 2006.
75. McCurnin DC, Pierce RA, Chang LY, Gibson LL, Osborne-Lawrence S, Yoder BA, Kerecman JD, Albertine KH, Winter VT, Coalson JJ, Crapo JD, Grubb PH, and Shaul PW. Inhaled NO improves early pulmonary function and modifies lung growth and elastin deposition in a baboon model of neonatal chronic lung disease. Am J Physiol Lung Cell Mol Physiol 288: L450-L459, 2005.
76. McElroy MC, Postle AD, and Kelly FJ. Catalase, superoxide dismutase and glutathione peroxidase activities of lung and liver during human development. Biochim Biophys Acta 1117: 153-158, 1992.
77. Mestan K, Matoba N, Arguelles L, Harvey C, Ernst LM, Farrow K, and Wang X. Cord blood 8-isoprostane in the preterm infant. Early Hum Dev 88: 683-689, 2012.
78. Montuschi P, Corradi M, Ciabattoni G, Nightingale J, Kharitonov SA, and Barnes PJ. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am J Respir Crit Care Med 160: 216-220, 1999.
79. Montuschi P, Mores N, Trove A, Mondino C, and Barnes PJ. The electronic nose in respiratory medicine. Respiration 85: 72-84, 2013.
80. Montuschi P, Paris D, Melck D, Lucidi V, Ciabattoni G, Raia V, Calabrese C, Bush A, Barnes PJ, and Motta A. NMR spectroscopy metabolomic profiling of exhaled breath condensate in patients with stable and unstable cystic fibrosis. Thorax 67: 222-228, 2012.
81. Morton RL, Das KC, Guo XL, Ikle DN, and White CW. Effect of oxygen on lung superoxide dismutase activities in premature baboons with bronchopulmonary dysplasia. Am J Physiol 276: L64-L74, 1999.
82. Motta A, Paris D, Melck D, de Laurentiis G, Maniscalco M, Sofia M, and Montuschi P. Nuclear magnetic resonance- based metabolomics of exhaled breath condensate: methodological aspects. Eur Respir J 39: 498-500, 2012.
83. Muzykantov VR. Delivery of antioxidant enzyme proteins to the lung. Antioxid Redox Signal 3: 39-62, 2001.
84. Muzykantov VR, Atochina EN, Ischiropoulos H, Danilov SM, and Fisher AB. Immunotargeting of antioxidant enzyme to the pulmonary endothelium. Proc Natl Acad Sci U S A 93: 5213-5218, 1996.
85. Nassi N, Ponziani V, Becatti M, Galvan P, and Donzelli G. Anti-oxidant enzymes and related elements in term and preterm newborns. Pediatr Int 51: 183-187, 2009.
86. Nozik-Grayck E, Dieterle CS, Piantadosi CA, Enghild JJ, and Oury TD. Secretion of extracellular superoxide dismutase in neonatal lungs. Am J Physiol Lung Cell Mol Physiol 279: L977-L984, 2000.
87. Nycyk JA, Drury JA, and Cooke RW. Breath pentane as a marker for lipid peroxidation and adverse outcome in preterm infants. Arch Dis Child Fetal Neonatal Ed 79: F67-F69, 1998.
88. Owen AD, Schapira AH, Jenner P, and Marsden CD. Oxidative stress and Parkinson's disease. Ann N Y Acad Sci 786: 217-223, 1996.
89. Padmanabhan RV, Gudapaty R, Liener IE, Schwartz BA, and Hoidal JR. Protection against pulmonary oxygen toxicity in rats by the intratracheal administration of liposome- encapsulated superoxide dismutase or catalase. Am Rev Respir Dis 132: 164-167, 1985.
90. Pagano A and Barazzone-Argiroffo C. Alveolar cell death in hyperoxia-induced lung injury. Ann N Y Acad Sci 1010: 405-416, 2003.
91. Palmer LA, Doctor A, Chhabra P, Sheram ML, Laubach VE, Karlinsey MZ, Forbes MS, Macdonald T, and Gaston B. S-nitrosothiols signal hypoxia-mimetic vascular pathology. J Clin Invest 117: 2592-2601, 2007.
92. Patel A, Lakshminrusimha S, Ryan RM, Swartz DD, Wang H, Wynn KA, and Kumar VH. Exposure to supplemental oxygen downregulates antioxidant enzymes and increases pulmonary arterial contractility in premature lambs. Neonatology 96: 182-192, 2009.
93. Perrone S, Tataranno ML, Negro S, Longini M, Marzocchi B, Proietti F, Iacoponi F, Capitani S, and Buonocore G. Early identification of the risk for free radical-related diseases in preterm newborns. Early Hum Dev 86: 241-244, 2010.
94. Pryor WA. Oxy-radicals and related species: their formation, lifetimes, and reactions. Annu Rev Physiol 48: 657-667, 1986.
95. Qanungo S and Mukherjea M. Ontogenic profile of some antioxidants and lipid peroxidation in human placental and fetal tissues. Mol Cell Biochem 215: 11-19, 2000.
96. Quinlan T, Spivack S, and Mossman BT. Regulation of antioxidant enzymes in lung after oxidant injury. Environ Health Perspect 102 Suppl 2: 79-87, 1994.
97. Rosenfeld W, Evans H, Concepcion L, Jhaveri R, Schaeffer H, and Friedman A. Prevention of bronchopulmonary dysplasia by administration of bovine superoxide dismutase in preterm infants with respiratory distress syndrome. J Pediatr 105: 781-785, 1984.
98. Shah MD and Shah SR. Nutrient deficiencies in the premature infant. Pediatr Clin North Am 56: 1069-1083, 2009.
99. Short EJ, Kirchner HL, Asaad GR, Fulton SE, Lewis BA, Klein N, Eisengart S, Baley J, Kercsmar C, Min MO, and Singer LT. Developmental sequelae in preterm infants having a diagnosis of bronchopulmonary dysplasia: analysis using a severity-based classification system. Arch Pediatr Adolesc Med 161: 1082-1087, 2007.
100. Short EJ, Klein NK, Lewis BA, Fulton S, Eisengart S, Kercsmar C, Baley J, and Singer LT. Cognitive and academic consequences of bronchopulmonary dysplasia and very low birth weight: 8-year-old outcomes. Pediatrics 112: e359, 2003.
101. Stabler SP, Morton RL, Winski SL, Allen RH, and White CW. Effects of parenteral cysteine and glutathione feeding in a baboon model of severe prematurity. Am J Clin Nutr 72: 1548-1557, 2000.
102. Stoll BJ, Hansen NI, Bell EF, Shankaran S, Laptook AR, Walsh MC, Hale EC, Newman NS, Schibler K, Carlo WA, Kennedy KA, Poindexter BB, Finer NN, Ehrenkranz RA, Duara S, Sanchez PJ, O'Shea TM, Goldberg RN, Van Meurs KP, Faix RG, Phelps DL, Frantz ID, 3rd, Watterberg KL, Saha S, Das A, and Higgins RD. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 126: 443-456, 2010.
103. Strange RC, Cotton W, Fryer AA, Jones P, Bell J, and Hume R. Lipid peroxidation and expression of copperzinc and manganese superoxide dismutase in lungs of premature infants with hyaline membrane disease and bronchopulmonary dysplasia. J Lab Clin Med 116: 666-673, 1990.
104. Tanswell AK and Freeman BA. Pulmonary antioxidant enzyme maturation in the fetal and neonatal rat. I. Developmental profiles. Pediatr Res 18: 584-587, 1984.
105. Teng RJ, Eis A, Bakhutashvili I, Arul N, and Konduri GG. Increased superoxide production contributes to the impaired angiogenesis of fetal pulmonary arteries with in utero pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 297: L184-L195, 2009.
106. Tyson JE, Wright LL, Oh W, Kennedy KA, Mele L, Ehrenkranz RA, Stoll BJ, Lemons JA, Stevenson DK, Bauer CR, Korones SB, and Fanaroff AA. Vitamin A supplementation for extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 340: 1962-1968, 1999.
107. van Klaveren RJ, Dinsdale D, Pype JL, Demedts M, and Nemery B. N-acetylcysteine does not protect against type II cell injury after prolonged exposure to hyperoxia in rats. Am J Physiol 273: L548-L555, 1997.
108. Vento M, Aguar M, Escobar J, Arduini A, Escrig R, Brugada M, Izquierdo I, Asensi MA, Sastre J, Saenz P, and Gimeno A. Antenatal steroids and antioxidant enzyme activity in preterm infants: influence of gender and timing. Antioxid Redox Signal 11: 2945-2955, 2009.
109. Villamor E, Kessels CG, Fischer MA, Bast A, de Mey JG, and Blanco CE. Role of superoxide anion on basal and stimulated nitric oxide activity in neonatal piglet pulmonary vessels. Pediatr Res 54: 372-381, 2003.
110. Walsh MC, Yao Q, Gettner P, Hale E, Collins M, Hensman A, Everette R, Peters N, Miller N, Muran G, Auten K, Newman N, Rowan G, Grisby C, Arnell K, Miller L, Ball B, and McDavid G. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics 114: 1305-1311, 2004.
111. Walther FJ, David-Cu R, and Lopez SL. Antioxidantsurfactant liposomes mitigate hyperoxic lung injury in premature rabbits. Am J Physiol 269: L613-L617, 1995.
112. Wani WY, Gudup S, Sunkaria A, Bal A, Singh PP, Kandimalla RJ, Sharma DR, and Gill KD. Protective efficacy of mitochondrial targeted antioxidant MitoQ against dichlorvos induced oxidative stress and cell death in rat brain. Neuropharmacology 61: 1193-1201, 2011.
113. Ward PA, Johnson KJ, and Till GO. Animal models of oxidant lung injury. Respiration 50 Suppl 1: 5-12, 1986.
114. Warner BB, Stuart LA, Papes RA, and Wispe JR. Functional and pathological effects of prolonged hyperoxia in neonatal mice. Am J Physiol 275: L110-L117, 1998.
115. Watterberg KL, Demers LM, Scott SM, and Murphy S. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 97: 210-215, 1996.
116. Watts JL, Milner R, Zipursky A, Paes B, Ling E, Gill G, Fletcher B, and Rand C. Failure of supplementation with vitamin E to prevent bronchopulmonary dysplasia in infants less than 1,500 g birth weight. Eur Respir J 4: 188-190, 1991.
117. Wedgwood S, McMullan DM, Bekker JM, Fineman JR, and Black SM. Role for endothelin-1-induced superoxide and peroxynitrite production in rebound pulmonary hypertension associated with inhaled nitric oxide therapy. Circ Res 89: 357-364, 2001.
118. Welty-Wolf KE, Simonson SG, Huang YC, Kantrow SP, Carraway MS, Chang LY, Crapo JD, and Piantadosi CA. Aerosolized manganese SOD decreases hyperoxic pulmonary injury in primates. II. Morphometric analysis. J Appl Physiol 83: 559-568, 1997.
119. White CW, Jackson JH, Abuchowski A, Kazo GM, Mimmack RF, Berger EM, Freeman BA, McCord JM, and Repine JE. Polyethylene glycol-attached antioxidant enzymes decrease pulmonary oxygen toxicity in rats. J Appl Physiol 66: 584-590, 1989.
120. Wilson AD and Baietto M. Advances in electronic-nose technologies developed for biomedical applications. Sensors (Basel) 11: 1105-1176, 2011.
121. Wispe JR, Warner BB, Clark JC, Dey CR, Neuman J, Glasser SW, Crapo JD, Chang LY, and Whitsett JA. Human Mn-superoxide dismutase in pulmonary epithelial cells of transgenic mice confers protection from oxygen injury. J Biol Chem 267: 23937-23941, 1992.
122. Yam J, Frank L, and Roberts RJ. Age-related development of pulmonary antioxidant enzymes in the rat. Proc Soc Exp Biol Med 157: 293-296, 1978.
123. Yi M, Jankov RP, Belcastro R, Humes D, Copland I, Shek S, Sweezey NB, Post M, Albertine KH, Auten RL, and Tanswell AK. Opposing effects of 60% oxygen and neutrophil influx on alveologenesis in the neonatal rat. Am J Respir Crit Care Med 170: 1188-1196, 2004.
124. Zhang X, Shan P, Sasidhar M, Chupp GL, Flavell RA, Choi AM, and Lee PJ. Reactive oxygen species and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase mediate hyperoxia-induced cell death in lung epithelium. Am J Respir Cell Mol Biol 28: 305-315, 2003.